Vanishing bile duct syndrome in human immunodeficiency virus: Nevirapine hepatotoxicity revisited

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 26

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

305

HTML

2972

Figures (1-4)

350

Tables (1-1)

167

Sum=3794

Jul 14, 2010 (publication date) through Nov 14, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Jul 14, 2010; 16(26): 3335-3338
Published online Jul 14, 2010. doi: 10.3748/wjg.v16.i26.3335

Full Size Figure Download Figure

Figure 4 Trend of liver enzymes and bilirubin during the patient’s clinical course.

Citation: Kochar R, Nevah MI, Lukens FJ, Fallon MB, Machicao VI. Vanishing bile duct syndrome in human immunodeficiency virus: Nevirapine hepatotoxicity revisited. World J Gastroenterol 2010; 16(26): 3335-3338
URL: https://www.wjgnet.com/1007-9327/full/v16/i26/3335.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i26.3335